With a strong educational background and practical experience in clinical research and education, I am excited to bring my passion for learning and teaching to the Clinical Research Protocol Educator role at Sarah Cannon Research Institute. Although I am newer to pediatric oncology, I am eager to expand my knowledge and deepen my expertise in oncology research. I have a proven ability to grasp complex clinical concepts quickly and translate them into clear, actionable training for multidisciplinary teams. My skills in developing educational materials, facilitating workshops, and supporting staff through protocol changes directly align with the responsibilities of this role. I am committed to staying at the forefront of clinical research advancements and am highly motivated to contribute to SCRI's innovative, mission-driven work. My dedication to advancing cancer care, strong grasp of clinical trial standards, and enthusiasm for empowering others to succeed make me a valuable addition to your team. I am ready to grow alongside SCRI, supporting both colleagues and patients through education, collaboration, and an unwavering commitment to excellence.
Experienced with clinical trials and research methodologies. Utilizes comprehensive knowledge of regulatory guidelines to ensure project success. Strong understanding of data management and effective team coordination.
Clinical research professional with strong foundation in managing research protocols and data analysis. Known for collaborative approach and adaptability to changing project needs. Proven skills in regulatory compliance and meticulous attention to detail.
CITI Program – Good Clinical Practice (GCP) Basic Course, COG Member
Completed September 1, 2026 | Expires September 1, 2029
CITI Program – Human Subjects Protection (HSP) Basic Course, COG Member
CITI Program – Good Clinical Practice (GCP) Basic Course, COG Member
Completed September 1, 2026 | Expires September 1, 2029
CITI Program – Human Subjects Protection (HSP) Basic Course, COG Member
Completed September 1, 2026
Children's Oncology Group (COG)
Member